advisorsecurities master

MBAICheck-Cap Ltd.

CSNasdaq (XNAS)·USD

Identity

Security key
18345
Ticker
MBAI
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2015-03-18
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
MBAI

Detail

Enriched 2026-08-14 20:47

Market cap
$1,402,507.99
Shares outstanding (class)
9,463,062
Shares outstanding (weighted)
1,104,337
SIC
Employees
85
Location
Description

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but plans to market products in the United States, Europe, Israel and Japan.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data